메뉴 건너뛰기




Volumn 20, Issue 4, 2016, Pages 448-455

Use of Xpert® MTB/RIF assay in the first national antituberculosis drug resistance survey in Pakistan

Author keywords

Drug resistance; MDR TB; Rifampicin; Surveillance; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

EID: 84961757605     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0645     Document Type: Review
Times cited : (34)

References (30)
  • 1
    • 84961767311 scopus 로고    scopus 로고
    • World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 5th ed. WHO/HTM/TB.13 Switzerland: WHO 2015
    • World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 5th ed. WHO/HTM/TB.13.2015. Geneva, Switzerland: WHO, 2015.
    • (2015) Geneva
  • 2
    • 79953731340 scopus 로고    scopus 로고
    • Modernizing surveillance of antituberculosis drug resistance: From special surveys to routine testing
    • Zignol M, van Gemert W, Falzon D, Jaramillo E, Blanc L, Raviglione M. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis 2011; 52: 901-906.
    • (2011) Clin Infect Dis , vol.52 , pp. 901-906
    • Zignol, M.1    Van Gemert, W.2    Falzon, D.3    Jaramillo, E.4    Blanc, L.5    Raviglione, M.6
  • 3
    • 79953758608 scopus 로고    scopus 로고
    • Evaluation of the GenoTypew MTBDRplus assay as a tool for drug resistance surveys
    • Rigouts L, Hoza A S, De Rijk P, et al. Evaluation of the GenoTypew MTBDRplus assay as a tool for drug resistance surveys. Int J Tuberc Lung Dis 2011; 15: 959-965.
    • (2011) Int J Tuberc Lung Dis , vol.15 , pp. 959-965
    • Rigouts, L.1    Hoza, A.S.2    De Rijk, P.3
  • 4
    • 84961766990 scopus 로고    scopus 로고
    • World Health Organization. Molecular line-probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement, Switzerland: WHO
    • World Health Organization. Molecular line-probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement. Geneva, Switzerland: WHO, 2008.
    • (2008) Geneva
  • 5
    • 84961681578 scopus 로고    scopus 로고
    • World Health Organization, Rapid implementation of the Xpert MTB/RIF diagnostic test. Geneva, Switzerland: WHO 2011. Accessed November 2015
    • World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test. Technical and operational how-To practical considerations. WHO/HTM/TB/2011.2. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789241501569-eng.pdf. Accessed November 2015.
    • (2011) Technical and Operational How-To Practical Considerations. WHO/HTM/TB/ , vol.2
  • 8
    • 84879461592 scopus 로고    scopus 로고
    • World Health Organization 4th ed. WHO/HTM/TB/ 2009. Geneva, Switzerland: WHO 2009. Accessed November 2015
    • World Health Organization. Guidelines for treatment of tuberculosis. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009. http://whqlibdoc.who.int/publications/2010/9789241547833-eng.pdf. Accessed November 2015.
    • Guidelines for Treatment of Tuberculosis , vol.420
  • 9
    • 84961739838 scopus 로고    scopus 로고
    • National Tuberculosis Control Programme Pakistan. National guidelines for the control of tuberculosis in Pakistan. Islamabad Pakistan: NTP Accessed November 2015
    • National Tuberculosis Control Programme Pakistan. National guidelines for the control of tuberculosis in Pakistan. Islamabad, Pakistan: NTP, 2015. http://www.ntp.gov.pk/resource.php Accessed November 2015.
    • (2015)
  • 11
    • 84907292496 scopus 로고    scopus 로고
    • World Health Organization WHO/HTM/TB/. Geneva, Switzerland: WHO 2014. Accessed November 2015
    • World Health Organization. Xpert MTB/RIF implementation manual. WHO/HTM/TB/2014.1. Geneva, Switzerland: WHO, 2014. http://apps.who.int/iris/bitstream/10665/112469/1/9789241506700-eng.pdf. Accessed November 2015.
    • (2014) Xpert MTB/RIF Implementation Manual , vol.1
  • 12
    • 40549095298 scopus 로고    scopus 로고
    • Prevalence of primary multidrug resistance to anti-Tuberculosis drugs in Pakistan
    • Javaid A, Hasan R, Zafar A, et al. Prevalence of primary multidrug resistance to anti-Tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis 2008; 12: 326-331.
    • (2008) Int J Tuberc Lung Dis , vol.12 , pp. 326-331
    • Javaid, A.1    Hasan, R.2    Zafar, A.3
  • 13
    • 0016152581 scopus 로고
    • A simple technique for culturing tubercle bacilli
    • Kudoh S, Kudoh T. A simple technique for culturing tubercle bacilli. Bull World Health Organ 1974; 51: 71-82.
    • (1974) Bull World Health Organ , vol.51 , pp. 71-82
    • Kudoh, S.1    Kudoh, T.2
  • 14
    • 0014622610 scopus 로고
    • Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes
    • Canetti G, Fox W, Khomenko A, Mitchison D A, Rist N, Smelev N A. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
    • (1969) Bull World Health Organ , vol.41 , pp. 21-43
    • Canetti, G.1    Fox, W.2    Khomenko, A.3    Mitchison, D.A.4    Rist, N.5    Smelev, N.A.6
  • 16
  • 17
    • 33846894072 scopus 로고    scopus 로고
    • Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda
    • Umubyeyi N A, Vandebriel G, Gasana M, et al. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Int J Tuberc Lung Dis 2006; 11:189-194.
    • (2006) Int J Tuberc Lung Dis , vol.11 , pp. 189-194
    • Umubyeyi, N.A.1    Vandebriel, G.2    Gasana, M.3
  • 18
    • 84876227698 scopus 로고    scopus 로고
    • Epidemiology of antituberculosis drug resistance in Saudi Arabia: Findings of the First National Survey
    • Al-Hajoj S, Varghese B, Shoukri M M, et al. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the First National Survey. Antimicrob Agents Chemother 2013; 57: 2161-2166.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 2161-2166
    • Al-Hajoj, S.1    Varghese, B.2    Shoukri, M.M.3
  • 19
    • 84881017109 scopus 로고    scopus 로고
    • Anti-Tuberculosis drug resistance among new and previously treated sputum smearpositive tuberculosis patients in Uganda: Results of the First National Survey
    • Lukoye D, Adatu F, Musisi K, et al. Anti-Tuberculosis drug resistance among new and previously treated sputum smearpositive tuberculosis patients in Uganda: results of the First National Survey. PLOS ONE 2013; 8: e70763.
    • (2013) PLOS ONE , vol.8 , pp. e70763
    • Lukoye, D.1    Adatu, F.2    Musisi, K.3
  • 20
    • 84861874346 scopus 로고    scopus 로고
    • National Survey of Drug-Resistant Tuberculosis in China
    • Zhao Y, Xu S, Wang L, et al. National Survey of Drug-Resistant Tuberculosis in China. N Engl J Med 2012; 366; 23.
    • (2012) N Engl J Med , vol.366 , pp. 23
    • Zhao, Y.1    Xu, S.2    Wang, L.3
  • 21
    • 77954715116 scopus 로고    scopus 로고
    • National antituberculosis drug resistance study in Tanzania
    • Chonde T M, Basra D, Mfinanga S G M, et al. National antituberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis 2010; 14: 967-972.
    • (2010) Int J Tuberc Lung Dis , vol.14 , pp. 967-972
    • Chonde, T.M.1    Basra, D.2    Mfinanga, S.G.M.3
  • 22
    • 84866111335 scopus 로고    scopus 로고
    • Diagnostic accuracy study of Xpert MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima
    • Carriquiry G, Otero L, González-Lagos E, et al. Diagnostic accuracy study of Xpert MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. PLOS ONE 2012; 7: e44626.
    • (2012) Peru. PLOS ONE , vol.7 , pp. e44626
    • Carriquiry, G.1    Otero, L.2    González-Lagos, E.3
  • 24
    • 79955571240 scopus 로고    scopus 로고
    • Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study
    • Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet 2011; 377: 1495-1505.
    • (2011) Lancet , vol.377 , pp. 1495-1505
    • Boehme, C.C.1    Nicol, M.P.2    Nabeta, P.3
  • 25
    • 77956497725 scopus 로고    scopus 로고
    • Rapid molecular detection of tuberculosis and rifampin resistance
    • Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
    • (2010) N Engl J Med , vol.363 , pp. 1005-1015
    • Boehme, C.C.1    Nabeta, P.2    Hillemann, D.3
  • 26
    • 84902336700 scopus 로고    scopus 로고
    • Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice
    • Kwak N, Choi S M, Lee J, et al. Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice. PLOS ONE 2013; 8: e77456.
    • (2013) PLOS ONE , vol.8 , pp. e77456
    • Kwak, N.1    Choi, S.M.2    Lee, J.3
  • 27
    • 84880576143 scopus 로고    scopus 로고
    • Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations
    • Rigouts L, Gumusboga M, Bram de Rijk W, et al. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol 2013; 51: 2641-2645.
    • (2013) J Clin Microbiol , vol.51 , pp. 2641-2645
    • Rigouts, L.1    Gumusboga, M.2    Bram De Rijk, W.3
  • 28
    • 84880609116 scopus 로고    scopus 로고
    • Rifampin drug resistance tests for tuberculosis: Challenging the gold standard
    • Van Deun A, Aung K J M, Bola V, et al. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol 2013; 51: 2633-2640.
    • (2013) J Clin Microbiol , vol.51 , pp. 2633-2640
    • Van Deun, A.1    Aung, K.J.M.2    Bola, V.3
  • 29
    • 84925067886 scopus 로고    scopus 로고
    • Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland
    • Sanchez-Padilla E, Merker M, Beckert P, et al. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med 2015; 372: 1181-1182.
    • (2015) N Engl J Med , vol.372 , pp. 1181-1182
    • Sanchez-Padilla, E.1    Merker, M.2    Beckert, P.3
  • 30
    • 84937155411 scopus 로고    scopus 로고
    • Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients
    • Van Deun A, Aung K J M, Hossain Md A, et al. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. Int J Tuberc Lung Dis 2015; 19: 185-190.
    • (2015) Int J Tuberc Lung Dis , vol.19 , pp. 185-190
    • Van Deun, A.1    Aung, K.J.M.2    Hossain Md, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.